NDC Package 72839-217-01 Dch Hemorrhoidal

Glycerin 14.4%,Lidocaine 5%,Petrolatum 15%,Phenylephrine Hcl 0.25% Cream Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
72839-217-01
Package Description:
1 TUBE in 1 CARTON / 28 g in 1 TUBE
Product Code:
Proprietary Name:
Dch Hemorrhoidal
Non-Proprietary Name:
Glycerin 14.4%, Lidocaine 5%, Petrolatum 15%, Phenylephrine Hcl 0.25%
Substance Name:
Glycerin; Lidocaine; Petrolatum; Phenylephrine Hydrochloride
Usage Information:
For the temporary relief of pain, soreness, and burning. Helps relieve the local itching and discomfort associated with hemorrhoids. Temporarily shrinks hemorrhoidal tissue. Temporarily provides a coating for the relief of anorectal discomforts. Temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful.
11-Digit NDC Billing Format:
72839021701
NDC to RxNorm Crosswalk:
  • RxCUI: 2642220 - glycerin 14.4 % / lidocaine 5 % / phenylephrine HCl 0.25 % / white petrolatum 15 % Rectal Cream
  • RxCUI: 2642220 - glycerin 144 MG/ML / lidocaine 50 MG/ML / petrolatum 150 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Rectal Cream
  • Product Type:
    Human Otc Drug
    Labeler Name:
    Derma Care Research Labs, Llc
    Dosage Form:
    Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Sample Package:
    No
    FDA Application Number:
    M015
    Marketing Category:
    OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
    Start Marketing Date:
    05-12-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 72839-217-01?

    The NDC Packaged Code 72839-217-01 is assigned to a package of 1 tube in 1 carton / 28 g in 1 tube of Dch Hemorrhoidal, a human over the counter drug labeled by Derma Care Research Labs, Llc. The product's dosage form is cream and is administered via topical form.

    Is NDC 72839-217 included in the NDC Directory?

    Yes, Dch Hemorrhoidal with product code 72839-217 is active and included in the NDC Directory. The product was first marketed by Derma Care Research Labs, Llc on May 12, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 72839-217-01?

    The 11-digit format is 72839021701. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-272839-217-015-4-272839-0217-01